M

Active Director Director DIN 10125700
DIN 10125700 First appointment Apr 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Mamta

Data last updated:

Mamta is a Director at Hayai Pharma Private Limited (since 2023). The company operates in Chemicals. Hayai Pharma Private Limited reported revenue of ₹46.4 Lakh (FY 2024).

DIN 10125700
Primary Designation Director
Industry Chemicals
First Appointment 19 Apr 2023
Oldest Company Age 4 yrs
Largest company Hayai Pharma Private Limited · ₹46.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hayai Pharma Private Limited U24290UP2022PTC169171
Director19 Apr 20232022₹46.4 Lakh (FY 2024)Active

Board colleagues of Mamta

NameDINCompanyDesignation
Sparsh Gupta09708018Hayai Pharma Private LimitedDirector
Vani Gupta11528820Hayai Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hayai Pharma Private Limited
Premium access

Shareholding and investment profile for Mamta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta

Mamta currently holds 1 directorship: Hayai Pharma Private Limited (Director, since 19 Apr 2023, revenue ₹46.4 Lakh (FY 2024)).

Mamta was first appointed on 19 Apr 2023 as Director at Hayai Pharma Private Limited.

The current boards of Mamta's companies include Sparsh Gupta (Hayai Pharma Private Limited), Vani Gupta (Hayai Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available